Oncology

Esthesioneuroblastoma

ORPHA:1957 ↗

Search all Esthesioneuroblastoma trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

7 Feb 2025

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 1NCT06479811

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Sponsor National Cancer Institute (NCI)Where United States (1 site)Studying 68Ga-DOTATATE, [203Pb]VMT-alpha-NETUpdated 18 Aug 2026

See details

RecruitingNCT04755205

A Natural History Study of Children and Adults With Olfactory Neuroblastoma

Sponsor National Cancer Institute (NCI)Where United States (1 site)Updated 17 Aug 2026

See details

RecruitingPhase 1 / Phase 2NCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Sponsor University of ArizonaWhere United States (2 sites)Studying Tarlatamab, Concurrent Radiation TherapyUpdated 20 Jul 2026

See details

RecruitingPhase 1 / Phase 2NCT06607692

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Sponsor Fundación de investigación HMWhere Spain (1 site)Studying Olaparib; 177Lu-DOTATATEUpdated 4 Jun 2026

See details

RecruitingPhase 2NCT06176989

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Sponsor National Cancer Institute (NCI)Where United States (1 site)Studying EnasidenibUpdated 3 Jun 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 10 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Spain United States

Keep watching

Get an email when a new Esthesioneuroblastoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:1957 ↗

About Esthesioneuroblastoma

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

5 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 2Etoposide (Etoposide)

Phase 2Gemcitabine (Gemzar)

Phase 2Rivoceranib

Phase 2Cyclophosphamide (Cyclophosphamide)

Phase 2Cisplatin (Cisplatin)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).